Anti-Human IL12B Recombinant Antibody(Briakinumab)
-
产品编号
YR1099
-
别名
科研级 Briakinumab ( 布雷奴单抗 ), Anti-IL12B Recombinant Antibody, Research Grade Briakinumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Briakinumab ( 布雷奴单抗 ), Anti-IL12B Recombinant Antibody, Research Grade Briakinumab |
| Catalog Number | YR1099 |
| Molecular Name | Briakinumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Lambda |
| Formulation | PBS, pH7.5 |
| Background | Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe. |
| CAS Number | 339308-60-0 |
| Application | FCM, IP, ELISA, Neut, FuncS |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Molecular Weight | 146.5 kDa |
| Target | IL12B[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
